WASHINGTON, D.C. (Sept. 22, 2016) -- More than 250 global food and health leaders representing the public and private sector gathered in Washington, D.C. this week at the One Health Summit, and declared priorities to help combat antimicrobial resistance as part of efforts to produce a sustainable food supply.
The One Health Summit explored the following three core areas and created outcomes to help animal agriculture deliver on their commitments to help combat antimicrobial resistance:
Outcome: Summit participants formed a working group to establish a pilot project to develop and test a model for increasing veterinary capacity and training. The World Veterinary Association (WVA) has agreed to chair the working group. The American Association of Veterinary Medical Colleges (AAVMC) has offered to convene stakeholders to explore funding opportunities and build capacity. Finally, the Gates Foundation stated they will work with stakeholders to build connections and consider funding support in countries aligned with the Foundation’s strategy.
Outcome: The Summit participants agreed to continue working together to develop a process to collect and harmonize data on global antibiotic use and resistance across all livestock sectors.
Outcome: A cross-functional working group formed to advance innovation and build public confidence in innovative solutions.
Tackling the challenge of antimicrobial resistance is bigger than one company or industry, requiring cross-sector stakeholders to come together. The One Health Summit is only the beginning – a catalyst for new actions and ideas to create a path forward.
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com and EnoughMovement.com.
Media Statement from the participants of the One Health Summit September 21-22 in Washington, D.C., related to the United Nations’ General Assembly call to action on global antimicrobial resistance.
As members of the global animal protein community, we support the United Nations efforts to combat antimicrobial resistance as part of our efforts to produce a safe, sustainable food supply. We’ll each do our part to help maintain antibiotics’ long-term effectiveness to ensure the health of people, animals and the planet. We have identified the following priorities for the industry to focus on:
We recognize the importance of healthy animals and their impact on human health and the health of the environment, as well as their role in meeting the expected 60 percent increase in protein demand. Healthy animals mitigate antimicrobial resistance potential and reduce disease spread. Healthy animals have a better quality of life and fulfill the growing need for meat, milk and eggs to nourish the increasing global population. Healthy animals use resources more efficiently, lessening our environmental footprint.
We will work across the global protein food chain and the health systems to address this critical societal need, using a balanced, One Health approach to protect the health of animals, people and the planet.
Cattle Empire, LLC
Country Bird Holdings, Ltd.
Deseret Ranches of Florida
Elanco Animal Health
Grupo Alimentario Guissona
Piensos Costa, S.A.
Pillen Family Farms
Wayne Farms, LLC